Concepedia

W.S. Adamus

WA

8

Publications

204

Citations

8

H-Index

1987

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Boehringer Ingelheim (Canada)

W.S. Adamus is an author at Boehringer Ingelheim (Germany) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1987–1995

8

Publications

8

Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings

W.S. Adamus, H. Heuer, Christopher J. Meade et al. · Clinical Pharmacology & Therapeutics · 1990 · 58 citations

Neuroendocrine and side effect profile of pramipexole, a new dopamine receptor agonist, in humans

Julian Schilling, W.S. Adamus, Rainer Palluk · Clinical Pharmacology & Therapeutics · 1992 · 41 citations

Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease

W.S. Adamus, Joachim Leonard, Wolfgang Tröger · Life Sciences · 1995 · 27 citations

, , +11

Safety, tolerability., and pharmacologic activity of multiple doses of the new platelet activating factor antagonist WEB 2086 in human subjects

W.S. Adamus, H. Heuer, Christopher J. Meade et al. · Clinical Pharmacology & Therapeutics · 1989 · 26 citations

Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man.

H. M. Brecht, W.S. Adamus, H. Heuer et al. · PubMed · 1991 · 16 citations

, , +13

Rows per page

1–5 of 8